BackShattuck Labs Overview
Shattuck Labs Inc

Shattuck Labs Target Price

See Shattuck Labs's analyst price targets ($13) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$8.06

Average Target Price

$13.2063.8% upside

5 analysts in the last 4 months

High: $18 | Low: $7

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-24Raymond JamesMartin Auster$18123.3% upsideOpen
2026-08-11H.C. WainwrightJoseph Pantginis$1473.7% upsideOpen
2026-07-20Leerink Partners$1698.5% upsideOpen
2026-06-05Jefferies$713.2% downsideOpen
2026-05-08Wedbush$1136.5% upsideOpen
2026-04-20H.C. Wainwright$18123.3% upsideOpen
2026-01-28Piper Sandler$1586.1% upsideOpen
2025-12-01H.C. Wainwright$625.6% downsideOpen
2025-08-14Leerink PartnersFaisal Khurshid$275.2% downsideOpen
2024-08-15CitigroupYigal Nochomovitz$80.7% downsideOpen
2024-06-20H.C. WainwrightJoseph Pantginis$1698.5% upsideOpen

Shattuck Labs (STTK) FAQ

The latest target price for STTK is $13. Investors often review this figure alongside Shattuck Labs's historical trend and sector peers before judging valuation or financial health.

Shattuck Labs trades near $8.06 while the consensus target sits at $13 (63.8% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting STTK's target price ($13), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Shattuck Labs's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.